Vimarsana
Biggest News Aggregation in the World

Onclive State News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Onclive State. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Onclive State Today - Breaking & Trending Today

CAR T-Cell Therapy vs Bispecific Antibodies: Picking an Approach in R/R DLBCL - Vimarsana News

CAR T-Cell Therapy vs Bispecific Antibodies: Picking an Approach in R/R DLBCL

Marie Hu, MD, discusses considerations for the use of CAR T-cell therapy and bispecific antibodies in relapsed/refractory diffuse large B-cell lymphoma.

Eckfeldt Looks Towards the Future of AML and MDS Care - Vimarsana News

Eckfeldt Looks Towards the Future of AML and MDS Care

Craig Eckfeldt, MD, PhD, discusses key updates in the MDS treatment paradigm and the implications of MRD testing, as well as next steps in the field of AML.

Which JAK Inhibitor in Myelofibrosis: Deciding Factors in Treatment Selection - Vimarsana News

Which JAK Inhibitor in Myelofibrosis: Deciding Factors in Treatment Selection

Rebecca Klisovic, MD, discusses 4 case studies of patients who presented with varying types of myelofibrosis and the appropriate treatment avenues for each patient.

Dr Nye on Future Treatment Directions in HER2+ Breast Cancer Brain Metastases - Vimarsana News

Dr Nye on Future Treatment Directions in HER2+ Breast Cancer Brain Metastases

Lauren E. Nye, MD, discusses future directions for the treatment of patients with HER2-positive breast cancer with brain metastases.

Improved Molecular Classification Drives Tailored Treatment Approaches in Endometrial Cancer - Vimarsana News

Improved Molecular Classification Drives Tailored Treatment Approaches in Endometrial Cancer

Abdulrahman Sinno, MD, discusses the paradigm shift from a histology-based to molecular-based understanding of endometrial cancer and its impact on treatment outcomes.